What's Hot

    College Applications Stress: I’m Trying Not to Nag My Kid About Apps | Invesloan.com

    March 11, 2026

    Crude oil is buying and selling like a ‘meme stock,’ these charts present | Invesloan.com

    March 11, 2026

    Kevin Hern launches Senate bid for Markwayne Mullin’s Oklahoma seat | Invesloan.com

    March 11, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » FDA launches AI-powered AEMS system to trace drug hostile occasions nationwide | Invesloan.com
    Politics

    FDA launches AI-powered AEMS system to trace drug hostile occasions nationwide | Invesloan.com

    March 11, 2026Updated:March 11, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email

    NEWYou can now listen to Fox News articles!

    FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health effects linked to medicines, vaccines, cosmetics, animal food and other consumer products.

    The FDA Adverse Event Monitoring System (AEMS) began operation Tuesday and will consolidate outdated systems used to process millions of adverse event reports and produce results in real time for consumers to access online. 

    “The FDA’s fragmented adverse event systems have wasted taxpayer dollars and created large blind spots in our post-market surveillance,” FDA Commissioner Dr. Marty Makary told Fox News Digital in a statement. “We’re addressing this critical issue by conducting a major modernization initiative on an accelerated timeline.” 

    “Moving forward, the FDA will have a single, intuitive adverse event platform that will better equip us and any interested researcher to access key data and insights about the safety of products on the market,” Makary added.

    DR. MAKARY, DR OZ: PEOPLE TALK ABOUT LOWERING HEALTHCARE COSTS, BUT THE TRUMP ADMINISTRATION IS DOING IT

    vaccination next to dr. marty makary

    The FDA has launched a new AI-powered website that allows consumers to search real-time reports of side effects tied to drugs, vaccines, cosmetics and other products. (iStock / Bill Clark/CQ-Roll Call, Inc via Getty Images)

    Adverse event reports are critical to determining the safety and effectiveness of certain drugs and products after they are approved for clinical trials and reach the wider consumer market, though the agency says the reports have been undermined due to current inefficient infrastructure.

    The general concept of AEMS is that consumers will be able to access the new website and search for FDA-approved cosmetics, drugs, vaccines, or foods that have adverse effect reports as they are reported by healthcare professionals, consumers, manufacturers, and user facilities for medical devices. 

    Travel cosmetic bag with the necessary means to care for women's skin. Cosmetics, dry shampoo, cotton buds, toothbrushes next cosmetic bag on a beige background. top view

    The FDA’s new AI-powered platform allows consumers to search reported adverse reactions linked to cosmetics and personal care products in real time.

    The agency estimates that roughly six to seven million adverse event reports per year are evaluated through a seven database system. The FDA says that the collective cost of utilizing the database is an estimated $37 million bill to taxpayers. AEMS is expected to save the FDA approximately $120 million over the next five years, according to the agency.

    FDA CLEARS FIRST AT-HOME BRAIN DEVICE FOR DEPRESSION

    The new website will be more accessible than the current quarterly report issued by the agency, and senior sources at the FDA told Fox News Digital they saw a 3000% increase in users in a pilot program that launched last September.

    “Consolidating the FDA’s adverse event systems and converting to real-time publication was challenging, but made possible by a highly aggressive schedule,” the FDA’s Chief AI Officer Jeremy Walsh told Fox News Digital in a statement. “The team executed with perfection and delivered the biggest technical transformation in agency history. This is the new FDA.”

    Marty Makary

    The agency says its revamped reporting system will improve transparency and make it simpler for Americans to view and eventually submit product safety reports online. (Getty Images)

    The legacy systems that are currently in place include the FDA Adverse Event Reporting System (FAERS),  Vaccine Adverse Event Reporting System (VAERS), and Adverse Event Reporting System (AERS), which will be replaced with the new system effective immediately. 

    In May, the AEMS will also replace the Manufacturer and User Facility Device Experience (MAUDE), Human Foods Complaint System (HFCS), and Center for Tobacco Products Adverse Event Reporting System (CTPAE).

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Each one of these systems will be integrated into the new AEMS, with artificial intelligence assisting for manual data entries and coding adverse events. 

    Sources at the FDA told Fox News Digital that the next phase of the rollout will be implementing a front-end system that makes it easy for reports to be submitted. The agency estimates that 80% of reports are never entered due to the complexity of filing a report — potentially resulting in some untold side effects never being made public. 

    Preston Mizell is a writer with Fox News. Story tips can be sent to [email protected] and on X @MizellPreston

    Preston Mizell is a writer with Fox News Digital covering breaking news.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    Kevin Hern launches Senate bid for Markwayne Mullin’s Oklahoma seat | Invesloan.com

    Philadelphia unlawful voting sparks considerations about ‘critical risk’ to democracy | Invesloan.com

    Texas GOP celebrates college alternative win for ‘instructional freedom’ in blow to lecturers unions | Invesloan.com

    Japan and Germany Say They Will Release Oil | Invesloan.com

    Obama Foundation CEO Valerie Jarrett earns $740,000 as govt payroll doubles | Invesloan.com

    Rep. Christian Menefee vows to proceed Trump impeachment efforts | Invesloan.com

    ICE says Camp East Montana detention facility staying open, not closing | Invesloan.com

    Trump is ‘on the poll’ in November midterms, Johnson says | Invesloan.com

    Justice Dept blasts ‘partisan’ DC Bar grievance towards senior Trump official | Invesloan.com

    LATEST NEWS

    College Applications Stress: I’m Trying Not to Nag My Kid About Apps | Invesloan.com

    March 11, 2026

    Crude oil is buying and selling like a ‘meme stock,’ these charts present | Invesloan.com

    March 11, 2026

    Kevin Hern launches Senate bid for Markwayne Mullin’s Oklahoma seat | Invesloan.com

    March 11, 2026

    We Left Off-Grid Life After Having a Kid; Better for Our Needs | Invesloan.com

    March 11, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}